If you have stricturing disease, previous bowel obstructions, or significant gastroparesis symptoms, your gastroenterologist may have concerns about the delayed gastric emptying effects of GLP-1 agonists
Drug exposure The study cohort consisted of new users of GLP-1RAs (dulaglutide, exenatide, liraglutide, lixisenatide or semaglutide), SGLT2 inhibitors (canagliflozin, dapagliflozin or empagliflozin), metformin and other second- or third-line glucose-lowering drugs (thiazolidinediones, dipeptidyl peptidase-4 inhibitors, sulfonylureas, meglitinides, -glucosidase inhibitors, insulin or a combination of glucose-lowering drugs)
Luque RM, Park S, Kineman RD
Zepbound My Custom Weight Loss Kit : A specialized formula to support weight management that combines five key compounds: metformin, bupropion, naltrexone, inositol, and vitamins B6 and B12
The precision is not optional